Company Overview and News
Good day and welcome to the Goodrich Petroleum First Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there'll be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
GDRRQ GDUEQ GDAOQ GDANQ GDPMQ GDP GDPM GDPAN GDPAQ
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
GDPMQ RACE PXD GDAOQ CATO GDRRQ AMC IAC PDCE SM IPXL BKE CCL ESTE BRK.A GDP CLDR GOOGL PNC FCAU BA GDPAN GDPAQ WFCNP LMT FB AIHS RCUS CPE GST-A EGY NOVN RAD BWB GST-B SLP GST LB ETH AXAS ADBE MYL SELB RYN AAPL CCL AMR DAL BBBY DIS WFC C GDPM CMCSA COST GDUEQ SIX PGEM BLK GDANQ JPM ZUMZ WRD BYD
Every now and then the elephant in the run stomps and makes a lot of noise. Investors had better pay attention because the problem that everyone hoped would never be voiced now makes the front pages followed by potentially more stock impact.
CRC PTQEP GDPMQ CHKVP SDRPQ CHKDH CHKVZ CHKDG CHKDJ GDAOQ CHKDP GDRRQ CKRGZ GDPM HKRCP SD CHKWZ GDUEQ SDOCQ GDANQ GDP CHK CHK.WI HK GDPAN SDRXP PQ SDRXQ GDPAQ
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...
as of ET